This observational study is following people with mood conditions to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
In United States
Why is this study shown?
This study is directly about Bipolarity.
BipolarityDrugA study involving a medication or substance.From 7 Years to 60 Years
This observational study is following people with Pediatric bipolarity to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
In United States
Why is this study shown?
This study is directly about Bipolarity.
BipolarityOtherFrom 6 Years to 17 Years
Countries
United States
Sponsor
The University of Texas Health Science Center, Houston
This observational study is following people with Hip Arthritis, Hip Disease, Hip Fractures, or Hip Injuries to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
In United States
Why is this study shown?
This study is directly about Bipolarity.
BipolarityDeviceA study involving a tool, app, wearable, test, or medical device.Over 18 Years
This observational study is looking at how a digital support tool works for people with bipolarity in routine care. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This study is looking at whether a digital support tool can help people with Migraine. Participants take part in a digital support tool and complete follow-up assessments.
This study exists to understand what helps a therapy or guided support program work in everyday practice, not just under ideal conditions. Researchers are trying to understand what a therapy or guided support program could change in day-to-day care and decision-making.
This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can better support energy, concentration, and everyday functioning.
This study exists to see whether the medication OPC-14597 can make care clearer and more responsive. Researchers are trying to understand whether the medication OPC-14597 can better prevent setbacks and support longer-term stability.
In United States
Why is this study shown?
This study is directly about Bipolarity.
BipolarityDrugFrom 18 Years to 65 Years
Countries
United States, Canada, Japan, ...
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.